THERAPEUTIC MODALITY

n

%

MONOTHERAPY

119

59.2

Beta-blockers

105

88.23

Carbonic anhydrase inhibitors

2

1.68

Prostaglandin agonists

12

10.08

BITHERAPY

77

38.3

Beta-blockers + Carbonic anhydrase inhibitors

49

63.63

Beta-blockers + Prostaglandin agonists

26

33.76

TRITHERAPY

5

2.5

Beta-blockers + Carbonic anhydrase inhibitors + Prostaglandin agonists

5

100